en

PRODUCT DETAIL

Lacosamide Adroiq 10 mg/ml infúzny roztok

Code 3742E
MA number EU/1/23/1732/001
Product Form: sol inf 5x20 ml/200 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 21 - ANTIEPILEPTICA, ANTICONVULSIVA
ATC:
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AX Other antiepileptics
N03AX18 Lacosamide
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 31.05.2023
Validity: 31.05.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 07.06.2023
eu-flag.png sk-flag.png